Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 7.608% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Cn1nc([N+](=O)[O-])c(C(C#N)c2ccccn2)c(Cl)c1=O
b: COc1cc(C(=O)N2CCN(C(=O)Cc3ccccc3)CC2)cc(OC)c1OC
Answer: a. Cn1nc([N+](=O)[O-])c(C(C#N)c2ccccn2)c(Cl)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1nc([N+](=O)[O-])c(C(C#N)c2ccccn2)c(Cl)c1=O
Cn1nc([N+](=O)[O-])c(C(C#N)c2ccccn2)c(Cl)c1=O
2-(5-chloro-1-methyl-3-nitro-6-oxopyridazin-4-yl)-2-pyridin-2-ylacetonitrile